NCOA6 and plasma cell myeloma: Dealing with myeloma cells, the peptides (mostly NRC-03) induced pore formation in the plasmalemma and DNA fragmentation; moreover, intratumoral injections of NRC-03 impaired the development of multiple myeloma xenografts in immunocompromised mice.